The top 10 core targets of YQWYF for DKD treatment were obtained by network pharmacology including TNF, IL6, AKT1, GAPDH, BCL2, ESR1, SRC, CTNNB1, EGFR, and PPARG. Here, SRC is linked to diabetic kidney disease.